{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:25:51Z","timestamp":1787498751710,"version":"build-2736575974"},"reference-count":43,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:00:00Z","timestamp":1756771200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"University of Lille, Inserm, and Genzyme Sanofi"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Central nervous system (CNS) disorders such as neurodegenerative diseases, multiple sclerosis, or even brain ischemia represent major therapeutic challenges with limited effective treatments. The sigma-1 receptor (S1R), a unique ligand-operated molecular chaperone enriched at mitochondria-associated membranes, has emerged as a promising drug target due to its role in neuroprotection and neuroinflammation. Building upon our previously identified S1R ligand (compound 1), we designed and synthesized six novel benzamide derivatives through pharmacomodulation to optimize affinity, selectivity, and safety profiles. Among these, compound 2 demonstrated superior S1R affinity, improved selectivity over the sigma-2 receptor (S2R), and favorable ADME properties, including enhanced permeability and markedly reduced in vitro cardiac toxicity compared to the lead compound. Functional assays confirmed the agonist activity of key derivatives, while safety evaluations revealed low cytotoxicity and minimal off-target receptor interactions. Collectively, these findings support compound 2 as a promising candidate for further preclinical development in S1R-related CNS disorders.<\/jats:p>","DOI":"10.3390\/molecules30173584","type":"journal-article","created":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T12:04:28Z","timestamp":1756814668000},"page":"3584","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Discovery of Novel Benzamide-Based Sigma-1 Receptor Agonists with Enhanced Selectivity and Safety"],"prefix":"10.3390","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8893-5155","authenticated-orcid":false,"given":"Pascal","family":"Carato","sequence":"first","affiliation":[{"name":"Univ. Lille, Inserm, CHU Lille, U1172-LilNCog-Lille Neuroscience & Cognition, F-59000 Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1199-7155","authenticated-orcid":false,"given":"B\u00e9n\u00e9dicte","family":"Oxombre","sequence":"additional","affiliation":[{"name":"Univ. Lille, Inserm, CHU Lille, U1172-LilNCog-Lille Neuroscience & Cognition, F-59000 Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9verine","family":"Ravez","sequence":"additional","affiliation":[{"name":"Univ. Lille, Inserm, CHU Lille, U1172-LilNCog-Lille Neuroscience & Cognition, F-59000 Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajaa","family":"Boulahjar","sequence":"additional","affiliation":[{"name":"Univ. Lille, Inserm, CHU Lille, U1172-LilNCog-Lille Neuroscience & Cognition, F-59000 Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Donnier-Mar\u00e9chal","sequence":"additional","affiliation":[{"name":"Univ. Lille, Inserm, CHU Lille, U1172-LilNCog-Lille Neuroscience & Cognition, F-59000 Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0028-1626","authenticated-orcid":false,"given":"Am\u00e9lie","family":"Barczyk","sequence":"additional","affiliation":[{"name":"Univ. Lille, Inserm, CHU Lille, U1286-INFINITE-Institute for Translational Research in Inflammation, F-59000 Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Liberelle","sequence":"additional","affiliation":[{"name":"Univ. Lille, Inserm, CHU Lille, U1172-LilNCog-Lille Neuroscience & Cognition, F-59000 Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0997-8817","authenticated-orcid":false,"given":"Patrick","family":"Vermersch","sequence":"additional","affiliation":[{"name":"Univ. Lille, Inserm, CHU Lille, U1172-LilNCog-Lille Neuroscience & Cognition, F-59000 Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9555-3446","authenticated-orcid":false,"given":"Patricia","family":"Melnyk","sequence":"additional","affiliation":[{"name":"Univ. Lille, Inserm, CHU Lille, U1172-LilNCog-Lille Neuroscience & Cognition, F-59000 Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,9,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e70378","DOI":"10.1111\/cns.70378","article-title":"Mitochondria-Associated Membranes: A Key Point of Neurodegenerative Diseases","volume":"31","author":"Zang","year":"2025","journal-title":"CNS Neurosci. Ther."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Jia, Z., Li, H., Xu, K., Li, R., Yang, S., Chen, L., Zhang, Q., Li, S., and Sun, X. (2024). MAM-mediated mitophagy and endoplasmic reticulum stress: The hidden regulators of ischemic stroke. Front. Cell. Neurosci., 18.","DOI":"10.3389\/fncel.2024.1470144"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Watanabe, S., and Yamanaka, K. (2025). Mitochondria and Endoplasmic Reticulum Contact Site as a Regulator of Proteastatic Stress Responses in Neurodegenerative Diseases. BioEssays, 47.","DOI":"10.1002\/bies.70016"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/978-3-030-12457-1_28","article-title":"At the Crossing of ER Stress and MAMs: A Key Role of Sigma-1 Receptor ?","volume":"1131","author":"Delprat","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s40263-023-01007-6","article-title":"Targeting Sigma Receptors for the Treatment of Neurodegenerative and Neurodevelopmental disorders","volume":"37","author":"Marlar","year":"2023","journal-title":"CNS Drugs"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1177\/0271678X241281547","article-title":"Sigma-1 receptor signaling: A Potential therapeutic approach for ischemic stroke","volume":"44","author":"Ngo","year":"2024","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"15187","DOI":"10.1021\/acs.jmedchem.0c01192","article-title":"Small Molecules Selectively Targeting Sigma-1 Receptor for the Treatment of Neurological Diseases","volume":"63","author":"Ye","year":"2020","journal-title":"J. Med. Chem."},{"key":"ref_8","first-page":"e12465","article-title":"Alzheimer\u2019s disease drug development pipeline: 2024","volume":"10","author":"Cummings","year":"2024","journal-title":"Alzheimers Dement."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"100016","DOI":"10.1016\/j.tjpad.2024.100016","article-title":"Blarcamesine for the treatment of Early Alzheimer\u2019d Disease: Results from the ANAVEX2-73-AD-004 Phase IIB\/III trial","volume":"12","author":"Macfarlane","year":"2025","journal-title":"J. Prev. Alzheimers Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"109027","DOI":"10.1016\/j.neuropharm.2022.109027","article-title":"Non-dopaminergic approaches to the treatment of motor complications in Parkinson\u2019s disease","volume":"210","author":"Cenci","year":"2022","journal-title":"Neuropharmacology"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Van de Roovaart, H.J., Nguyen, N., and Veenstra, T.D. (2023). Huntington\u2019s Disease Drug Development: A Phase 3 Pipeline Analysis. Pharmaceuticals, 16.","DOI":"10.3390\/ph16111513"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"4828","DOI":"10.1016\/j.bmcl.2005.07.040","article-title":"Synthesis and pharmacological evaluation of Tic-Hydantoin derivatives as selective \u03c31 ligands. Part 2","volume":"15","author":"Charton","year":"2005","journal-title":"Bioorganic Med. Chem. Lett."},{"key":"ref_13","first-page":"1","article-title":"Neuroprotective and antidepressant-like effects of LC 03\/55, a novel sigma-1 receptor ligand","volume":"22","author":"Venna","year":"2008","journal-title":"Fundam. Clin. Pharmacol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1111\/bph.13037","article-title":"High affinity sigma-1 receptor agonist reduces clinical and pathological signs of experimental auto-immune encephalomyelitis","volume":"172","author":"Oxombre","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.ejmech.2017.07.014","article-title":"Synthesis and pharmacological evaluation of benzamide derivatives as potent and selective sigma-1 ligands","volume":"138","author":"Carato","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Oxombre, B., Madouri, F., Journ\u00e9, A.S., Ravez, S., Woitrain, E., Odou, P., Duhal, N., Ninni, S., Montaigne, D., and Delhem, N. (2022). Safe and efficient sigma1 ligand: A potential drug candidate for Multiple Sclerosis. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms231911893"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0022-3565(24)38131-5","article-title":"Molecular and ligand-binding characterization of the sigma-receptor in the Jurkat human T lymphocyte cell line","volume":"289","author":"Ganapathy","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/nature17391","article-title":"Crystal structure of the human \u03c31 receptor","volume":"532","author":"Schmidt","year":"2016","journal-title":"Nature"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1177\/108705710200700108","article-title":"Adaptation of Aequorin Functional Assay to High Throughput Screening","volume":"7","author":"Hisada","year":"2002","journal-title":"J. Biomol. Screen."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"22","DOI":"10.2174\/1875397300903010022","article-title":"HTRF: A Technology Tailored for Drug Discovery\u2014A Review of Theoretical Aspects and Recent Applications","volume":"3","author":"Degorce","year":"2009","journal-title":"Curr. Chem. Genom."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1089\/15406580360545071","article-title":"A fully automated [35S]GTPgammaS scintillation proximity assay for the high-throughput screening of Gi-linked G protein-coupled receptors","volume":"1","author":"Ferrer","year":"2003","journal-title":"Assay Drug Dev. Technol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.cell.2007.08.036","article-title":"Sigma-1 Receptor Chaperones at the ER-Mitochondrion Interface Regulate Ca2+ Signaling and Cell Survival","volume":"131","author":"Hayashi","year":"2007","journal-title":"Cell"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/0006-8993(94)91397-8","article-title":"Behavioral Evidence for a Modulating Role of Sigma Ligands in Memory Processes. I. Attenuation of Dizocilpine (MK-801)-Induced Amnesia","volume":"647","author":"Maurice","year":"1994","journal-title":"Brain Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"4345","DOI":"10.1016\/j.apsb.2024.06.013","article-title":"Amylovis-201 is a dual-target ligand, acting as an anti-amyloidogenic compound and a potent agonist of the sigma-1 chaperone protein","volume":"14","author":"Crouzier","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/S0016-5085(89)80072-1","article-title":"Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability","volume":"96","author":"Hidalgo","year":"1989","journal-title":"Gastroenterology"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1002\/jps.10332","article-title":"Development and validation of a 96-well equilibrium dialysis apparatus for measuring plasma protein binding","volume":"92","author":"Banker","year":"2003","journal-title":"J. Pharm. Sci."},{"key":"ref_28","first-page":"23","article-title":"A method for the simultaneous evaluation of the activities of seven major human drug-metabolizing cytochrome P450s using an in vitro cocktail of probe substrates and fast gradient liquid chromatography tandem mass spectrometry","volume":"29","author":"Dierks","year":"2001","journal-title":"Drug Metab. Dispos."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"4548","DOI":"10.1021\/jm2001629","article-title":"Profiling of a Prescription Drug Library for Potential Renal Drug\u2013Drug Interactions Mediated by the Organic Cation Transporter 2","volume":"54","author":"Kido","year":"2011","journal-title":"J. Med. Chem."},{"key":"ref_30","first-page":"G157","article-title":"Expression and transport properties of the human ileal and renal sodium-dependent bile acid transporter","volume":"274","author":"Craddock","year":"1998","journal-title":"Am. J. Physiol. Liver Physiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ijpharm.2009.09.037","article-title":"Identification and functional characterization of breast cancer resistance protein in human bronchial epithelial cells (Calu-3)","volume":"384","author":"Paturi","year":"2010","journal-title":"Int. J. Pharm."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/S0022-3565(24)29493-3","article-title":"Multidrug resistance-associated protein-1 functional activity in Calu-3 cells","volume":"298","author":"Hamilton","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1007\/s11095-009-9896-0","article-title":"Identification of novel specific and general inhibitors of the three major human ATP-binding cassette transporters P-gp, BCRP and MRP2 among registered drugs","volume":"26","author":"Matsson","year":"2009","journal-title":"Pharm. Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1124\/dmd.106.012765","article-title":"Inhibition of MRP1\/ABCC1, MRP2\/ABCC2, and MRP3\/ABCC3 by nucleoside.; nucleotide.; and non-nucleoside reverse transcriptase inhibitors","volume":"35","author":"Weiss","year":"2007","journal-title":"Drug Metab. Dispos."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0022-3565(24)35228-0","article-title":"Modulation by drugs of human hepatic sodium-dependent bile acid transporter (sodium taurocholate cotransporting polypeptide) activity","volume":"291","author":"Kim","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1006\/abio.2000.4633","article-title":"Fluorescence-based assay for the interaction of small molecules with the human renal organic anion transporter 1","volume":"283","author":"Cihlar","year":"2000","journal-title":"Anal. Biochem."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1875397301004010001","article-title":"Development of a Cell-Based High-Throughput Assay to Screen for Inhibitors of Organic Anion Transporting Polypeptides 1B1 and 1B3","volume":"4","author":"Gui","year":"2010","journal-title":"Curr. Chem. Genom."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0022-3565(24)29270-3","article-title":"Rational use of in vitro P-glycoprotein assays in drug discovery","volume":"299","author":"Polli","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction","volume":"22","author":"Cheng","year":"1973","journal-title":"Biochem. Pharmacol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1124\/dmd.110.033126","article-title":"Cytochrome P450 3A4 mRNA Is a More Reliable Marker than CYP3A4 Activity for Detecting Pregnane X Receptor-Activated Induction of Drug-Metabolizing Enzymes","volume":"38","author":"Fahmi","year":"2010","journal-title":"Drug Metab. Dispos."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1517\/14728222.10.2.319","article-title":"QPatch: The past, present and future of automated patch clamp","volume":"10","author":"Mathes","year":"2006","journal-title":"Expert Opin. Ther. Targets"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13321-025-00973-x","article-title":"GNINA 1.3: The next increment in molecular docking with deep learning (Primary application citation)","volume":"17","author":"McNutt","year":"2025","journal-title":"J. Cheminformatics"},{"key":"ref_43","unstructured":"Melnyk, P., Vermersch, P., Carato, P., Vanteghem-Oxombre, B., Zephir, H., and Donnier-Mar\u00e9chal, M. (2014). Compounds, Pharmaceutical Composition and Their Use in Treating Neurodegenerative Diseases. (WO\/2015\/193255), Patent."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/30\/17\/3584\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:37:58Z","timestamp":1760035078000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/30\/17\/3584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,2]]},"references-count":43,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["molecules30173584"],"URL":"https:\/\/doi.org\/10.3390\/molecules30173584","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,2]]}}}